SLC26A3 and Hyperoxaluria: Thus, there is uncertainty about whether SLC26A3 mediates physiologically significant oxalate transport and, therefore, whether SLC26A3 inhibition would be therapeutically beneficial for conditions associated with hyperoxaluria.